MiMedx
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2008-02-28
- Employees
- 895
- Market Cap
- -
- Website
- http://www.mimedx.com
- Introduction
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
- Conditions
- Plantar Fasciitis
- Interventions
- Other: MarcaineOther: SalineOther: 0.5cc AmnioFixOther: 1.25cc AmnioFix
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2013-12-11
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT01659827
- Locations
- ๐บ๐ธ
Professional Education and Research Institute, Salem, Virginia, United States
Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Other: Weekly application of EpiFix plus standard of careOther: Biweekly application of EpiFix plus standard of care
- First Posted Date
- 2012-08-06
- Last Posted Date
- 2013-12-11
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01657474
- Locations
- ๐บ๐ธ
Professional Education and Research Institute, Salem, Virginia, United States
Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Other: Standard of careOther: Applications of EpiFix
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2015-08-17
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT01552499
- Locations
- ๐บ๐ธ
Professional Education and Research Institute, Roanoke, Virginia, United States
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
- Conditions
- Venous Leg Ulcer
- Interventions
- Other: EpiFixOther: Compression Therapy
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT01552447
- Locations
- ๐บ๐ธ
Eric J. Lullove DPM, Boca Raton, Florida, United States
๐บ๐ธSt. Vincent's Health Center, Erie, Pennsylvania, United States
๐บ๐ธArmstrong County Memorial Hospital, Kittanning, Pennsylvania, United States
An Evaluation of the Effect of the AmnioFix Amniotic Membrane Allograft in Patients Undergoing Posterior Instrumentation Removal
- Conditions
- Adhesions of Soft Tissue
- Interventions
- Other: Scheduled removal of posterior instrumentation without AmnioFixOther: Scheduled removal of posterior instrumentation with AmnioFix
- First Posted Date
- 2011-05-20
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- MiMedx Group, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT01357187
- Locations
- ๐บ๐ธ
Virginia Spine Institute, Reston, Virginia, United States